Asterand
www.asterand.com
www.asterand.com
Asterand plc is the leading global supplier of high quality, well characterized human tissue and human tissue-based research services to drug discovery scientists. Their mission is to provide human tissues and services to accelerate the identification and validation of drug targets and enhance the selection of drug candidates with an increased likelihood of clinical success.
Sorry, no articles available.
Page 1 of 2, showing 50 records out of 55 total, starting on record 1, ending on 50
-
03/05/12
Asterand exploring alternatives for sale of subsidary -
01/05/12
Asterand to sell BioSeek and other main business separately -
29/03/12
Asterand lifted by news of extended BioSeek/Merck Serono collaboration -
06/03/12
Asterand still confident of sale but says will take longer to complete -
05/01/12
Asterand extends deadline for potential takeover bids -
30/11/11
Asterand subsidiary achieves “research milestone” with Japanese partner -
30/11/11
Asterand’s shares up almost 10 per cent after “research milestone” achieved -
18/11/11
Asterand extends sale process deadline -
08/11/11
Asterand secures no-cost extension to NCI contract -
23/09/11
Asterand’s NCI supply deal set to finish early due to partner’s funding issues -
29/07/11
Asterand CEO Coombs steps down -
13/06/11
Asterand CEO buys 85,000 shares in company -
17/05/11
Asterand reports 30% increase in revenue in first four months of 2011 -
04/05/11
Asterand results beat broker expectations -
28/04/11
Asterand 2010 revenues jump as BioSeek sales soar 68pct -
14/04/11
Asterand’s Detroit facility gets key ISO certification, shares rise -
29/03/11
Asterand and 5AM Solutions team up to develop virtual biobanking software -
24/01/11
Asterand surges as stock market historian David Schwartz makes it his prime pick -
17/12/10
The quiet revolution that promises to transform Asterand -
09/12/10
Asterand allays fears over cash call as it raises debt to fund BioSeek deal -
04/11/10
Asterand CEO Coombs buys 80,000 more shares in co -
03/11/10
Asterand revenue grew 30% in Q3 -
25/10/10
Asterand is one of Daniel Stewart’s healthcare stockpicks -
08/10/10
Asterand's Coombs says NCI supply contract will make a 'material difference' to business -
04/10/10
Daniel Stewart & Co raises forecasts for Asterand after contract win -
23/09/10
Asterand`s BioSeek subsidiary signs collaboration deal with Cellzone -
22/09/10
Asterand names Dr Dalia Cohen chief scientific officer -
26/08/10
Asterand 'has weathered the worst of the storm' -
08/07/10
Religare sees Asterand building a strong franchise in research outsourcing market -
14/06/10
Asterand and Amylin Pharmaceuticals ink one year peptide discovery collaboration -
14/06/10
Asterand’s BioSeek lands another new contract as Amylin Pharmaceuticals looks for new peptides -
07/06/10
Asterand’s BioSeek unit receives US$1.5m from extension to US EPA’s ToxCast screening program -
17/05/10
Asterand CFO John Stchur wins ‘Financial Director of the Year Outside the FTSE 350 Award’ -
19/04/10
Asterand: investing for the future -
01/04/10
Asterand results in line with broker forecasts, looks to 2010 with optimism -
23/03/10
Asterand’s BioSeek enters discovery collaboration agreement with Ono Pharmaceuticals -
01/03/10
Asterand widens service offering with UK Good Laboratory Practice membership -
18/02/10
Asterand completes BioSeek acquisition marking first step in ‘buy-and-build’ strategy -
09/02/10
Daniel Stewart still sees 50% upside for Asterand shares, reiterates 'buy' -
04/02/10
Asterand posts documentation on proposed BioSeek acquisition to shareholders -
15/01/10
Asterand confident in strong growth prospects as BioSeek acquisition progresses well -
23/11/09
Asterand’s BioSeek acquisition ‘a solid asset at a winning price’ says Daniel Stewart -
23/11/09
Asterand and Bristol-Myers Squibb extend compound profiling collaboration -
18/11/09
Asterand to buy US drug discovery services group BioSeek, 9 mths trading ‘encouraging’ -
03/09/09
Daniel Stewart still says ‘buy’ Asterand, sees company delivering constant growth -
27/08/09
Asterand first half revenues climb, company swings to first half profit -
20/07/09
Asterand in research collaboration with Denmark’s Lundbeck -
16/06/09
Asterand’s John Stchur named CFO of the Year by Crain’s Detroit Business -
09/06/09
Asterand price target raised at Daniel Stewart, still ‘buy’ -
27/05/09
Martyn Coombs of Asterand nominated for CEO of the year at European Mediscience Awards
Sorry, no media files found.
